| Nonfasting hyperlipidemia and cardiovascular disease. | |
| | |
MedLine Citation:
|
PMID: 19355857 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Most humans are in the nonfasting or postprandial state in the majority of a 24 hour cycle; however, lipids, lipoproteins, and apolipoproteins are usually measured in the fasting state. Recent studies demonstrate that these values at most change minimally in response to normal food intake, changes that are clinically unimportant. Also, elevated levels of nonfasting triglycerides as a marker of elevated remnant lipoprotein cholesterol associate strongly with increased risk of myocardial infarction, ischemic stroke, and early death. The mechanism behind these findings likely involves entrance of remnant lipoproteins into the arterial intima with subsequent retention leading to atherogenesis, while low HDL cholesterol levels may be an innocent bystander. Finally, nonfasting levels of total cholesterol, non-HDL cholesterol, LDL cholesterol, apolipoprotein B, triglycerides, HDL cholesterol, apolipoprotein A1, total cholesterol/HDL cholesterol, and apolipoprotein B/apolipoprotein A1 all associate with increased risk of cardiovascular disease. These new data open the possibility that nonfasting rather than fasting lipid profiles can be used for cardiovascular risk prediction. If implemented, this would simplify blood sampling for lipid measurements for millions of patients worldwide. Furthermore, the results also highlight the need for randomized double-blind trials of new and established drugs to reduce nonfasting triglycerides and remnant lipoprotein cholesterol, with the ultimate aim of reducing risk of cardiovascular disease and early death. |
| | |
Authors:
|
B G Nordestgaard; A Langsted; J J Freiberg |
Related Documents
:
|
8222487 - High-density lipoprotein cholesterol elevation with gemfibrozil: effects of baseline le... 7604787 - Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in comb... 21461207 - Raw food diets in companion animals: a critical review. 21073127 - Glycogen storage disease type iii with hypoketosis. 7754997 - Health implications of mediterranean diets in light of contemporary knowledge. 2. meat,... 12872047 - Function and regulation of the vanilloid receptor in rats fed a high salt diet. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Current drug targets Volume: 10 ISSN: 1873-5592 ISO Abbreviation: Curr Drug Targets Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-04-09 Completed Date: 2009-09-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100960531 Medline TA: Curr Drug Targets Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 328-35 Citation Subset: IM |
Affiliation:
|
Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Denmark. brno@heh.regionh.dk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cardiovascular Diseases / blood*, diagnosis, prevention & control Fasting / blood* Hematologic Tests / methods Humans Hyperlipidemias / blood*, diagnosis, prevention & control Risk Factors |
| Comments/Corrections | |
Comment In:
|
Curr Drug Targets. 2009 Apr;10(4):299-301
[PMID:
19355854
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Triglycerides and vascular risk: insights from epidemiological data and interventional studies.
Next Document: Primary and secondary hypertriglyceridaemia.